These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 38770776

  • 1. The TAC1 Gene in Candida albicans: Structure, Function, and Role in Azole Resistance: A Mini-Review.
    Mahdizade AH, Hoseinnejad A, Ghazanfari M, Boozhmehrani MJ, Bahreiny SS, Abastabar M, Galbo R, Giuffrè L, Haghani I, Romeo O.
    Microb Drug Resist; 2024 Jul; 30(7):288-296. PubMed ID: 38770776
    [Abstract] [Full Text] [Related]

  • 2. Mediator Tail Module Is Required for Tac1-Activated CDR1 Expression and Azole Resistance in Candida albicans.
    Liu Z, Myers LC.
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807920
    [Abstract] [Full Text] [Related]

  • 3. Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates.
    Coste A, Selmecki A, Forche A, Diogo D, Bougnoux ME, d'Enfert C, Berman J, Sanglard D.
    Eukaryot Cell; 2007 Oct; 6(10):1889-904. PubMed ID: 17693596
    [Abstract] [Full Text] [Related]

  • 4. Induction of Candida albicans drug resistance genes by hybrid zinc cluster transcription factors.
    Schneider S, Morschhäuser J.
    Antimicrob Agents Chemother; 2015 Jan; 59(1):558-69. PubMed ID: 25385116
    [Abstract] [Full Text] [Related]

  • 5. Distinct roles of Candida albicans drug resistance transcription factors TAC1, MRR1, and UPC2 in virulence.
    Lohberger A, Coste AT, Sanglard D.
    Eukaryot Cell; 2014 Jan; 13(1):127-42. PubMed ID: 24243794
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations.
    Jensen RH, Astvad KM, Silva LV, Sanglard D, Jørgensen R, Nielsen KF, Mathiasen EG, Doroudian G, Perlin DS, Arendrup MC.
    J Antimicrob Chemother; 2015 Sep; 70(9):2551-5. PubMed ID: 26017038
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Selected mechanisms of molecular resistance of Candida albicans to azole drugs.
    Gołąbek K, Strzelczyk JK, Owczarek A, Cuber P, Ślemp-Migiel A, Wiczkowski A.
    Acta Biochim Pol; 2015 Sep; 62(2):247-51. PubMed ID: 25901298
    [Abstract] [Full Text] [Related]

  • 11. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D, Coste AT.
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reduced susceptibility of Candida albicans clinical isolates to azoles and detection of mutations in the ERG11 gene.
    Zhang L, Yang HF, Liu YY, Xu XH, Ye Y, Li JB.
    Diagn Microbiol Infect Dis; 2013 Dec; 77(4):327-9. PubMed ID: 24070847
    [Abstract] [Full Text] [Related]

  • 15. The zinc cluster transcription factor Znc1 regulates Rta3-dependent miltefosine resistance in Candida albicans.
    Ramírez-Zavala B, Krüger I, Schwanfelder S, Barker KS, Rogers PD, Morschhäuser J.
    mSphere; 2024 Jul 30; 9(7):e0027024. PubMed ID: 38860767
    [Abstract] [Full Text] [Related]

  • 16. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
    Mane A, Vidhate P, Kusro C, Waman V, Saxena V, Kulkarni-Kale U, Risbud A.
    Mycoses; 2016 Feb 30; 59(2):93-100. PubMed ID: 26648048
    [Abstract] [Full Text] [Related]

  • 17. The transcription factor Ndt80 does not contribute to Mrr1-, Tac1-, and Upc2-mediated fluconazole resistance in Candida albicans.
    Sasse C, Schillig R, Dierolf F, Weyler M, Schneider S, Mogavero S, Rogers PD, Morschhäuser J.
    PLoS One; 2011 Feb 30; 6(9):e25623. PubMed ID: 21980509
    [Abstract] [Full Text] [Related]

  • 18. Deciphering azole resistance mechanisms with a focus on transcription factor-encoding genes TAC1, MRR1 and UPC2 in a set of fluconazole-resistant clinical isolates of Candida albicans.
    Morio F, Pagniez F, Besse M, Gay-andrieu F, Miegeville M, Le Pape P.
    Int J Antimicrob Agents; 2013 Nov 30; 42(5):410-5. PubMed ID: 24051054
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.